The first needle-free emergency treatment for anaphylaxis – in the form of a nasal spray – will now be available in the UK.

The first needle-free emergency treatment for anaphylaxis - in the form of a nasal spray - will now be available in the UK.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for EURneffy, an adrenaline ...

A nasal spray formulation of adrenaline, a needle-free alternative in the emergency treatment of anaphylaxis, has been ...

Newly approved needle-free adrenaline spray offers longer shelf life, better stability, and easier use, signaling a shift in emergency drug delivery design.

In a landmark development for allergy sufferers, the United Kingdom has become one of the first countries in the world to ...

Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 18 July 2025, approved adrenaline (epinephrine) ...

Intranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...

EURneffy is the trade name for neffy® (epinephrine nasal spray) in the United Kingdom. About neffy® neffy is a nasal spray used for emergency treatment of allergic reactions including anaphylaxis, in ...

The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

Do not use KLOXXADO ® Nasal Spray if you are allergic to naloxone hydrochloride or any of the ingredients in KLOXXADO ® Nasal Spray. What are the most common side effects of KLOXXADO® nasal spray?